Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("OLD, Lloyd")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 127

  • Page / 6
Export

Selection :

  • and

Immunotherapeutic strategies for high-risk bladder cancerSHARMA, Padmanee; OLD, Lloyd J; ALLISON, James P et al.Seminars in oncology. 2007, Vol 34, Num 2, pp 165-172, issn 0093-7754, 8 p.Article

Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion : Cancer Crusade at 40SCHREIBER, Robert D; OLD, Lloyd J; SMYTH, Mark J et al.Science (Washington, D.C.). 2011, Vol 331, Num 6024, pp 1565-1570, issn 0036-8075, 6 p.Article

KP-CoT-23 (CCDC83) is a novel immunogenic cancer/testis antigen in colon cancerSONG, Myung-Ha; HA, Jin-Mok; SHIN, Dong-Hoon et al.International journal of oncology. 2012, Vol 41, Num 5, pp 1820-1826, issn 1019-6439, 7 p.Article

Vaccination With a Recombinant Protein Encoding the Tumor-specific Antigen NY-ESO-1 Elicits an A2/157-165-specific CTL Repertoire Structurally Distinct and of Reduced Tumor Reactivity Than That Elicited by Spontaneous Immune Responses to NY-ESO-1-expressing TumorsBIOLEY, Gilles; GUILLAUME, Philippe; LUESCHER, Immanuel et al.Journal of immunotherapy (1997). 2009, Vol 32, Num 2, pp 161-168, issn 1524-9557, 8 p.Article

CD4+ CD25+ regulatory T cells control the induction of antigen-specific CD4+ helper T cell responses in cancer patientsNISHIKAWA, Hiroyoshi; JÄGER, Elke; RITTER, Gerd et al.Blood. 2005, Vol 106, Num 3, pp 1008-1011, issn 0006-4971, 4 p.Article

The SSX gene family: Characterization of 9 complete genesGÜRE, Ali O; WEI, Isaac J; OLD, Lloyd J et al.International journal of cancer. 2002, Vol 101, Num 5, pp 448-453, issn 0020-7136, 6 p.Article

Antibody inhibiting enzymatic activity of tumour-associated carbonic anhydrase isoform IXMURRI-PLESKO, Margarita T; HULIKOVA, Alzbeta; RENNER, Christoph et al.European journal of pharmacology. 2011, Vol 657, Num 1-3, pp 173-183, issn 0014-2999, 11 p.Article

Expression of the human cancer/testis antigen NY-SAR-35 is activated by CpG island hypomethylationPARK, Jin-Hyung; SONG, Myung-Ha; LEE, Chang-Hun et al.Biotechnology letters. 2011, Vol 33, Num 6, pp 1085-1091, issn 0141-5492, 7 p.Article

A novel cancer/testis antigen KP-OVA-52 identified by SEREX in human ovarian cancer is regulated by DNA methylationKIM, Kang-Mi; SONG, Myung-Ha; KIM, Min-Ju et al.International journal of oncology. 2012, Vol 41, Num 3, pp 1139-1147, issn 1019-6439, 9 p.Article

Identification of Tumor-Associated Antigens from Medullary Breast Carcinoma by a Modified SEREX ApproachKIYAMOVA, Ramziya; KOSTIANETS, Olga; MALYUCHIK, Sergey et al.Molecular biotechnology. 2010, Vol 46, Num 2, pp 105-112, issn 1073-6085, 8 p.Article

Chromosome X-encoded cancer/testis antigens show distinctive expression patterns in developing gonads and in testicular seminomaCHEN, Yao-Tseng; CHIU, Rita; LEE, Peishan et al.Human reproduction (Oxford. Print). 2011, Vol 26, Num 12, pp 3232-3243, issn 0268-1161, 12 p.Article

Oncogenomics and the development of new cancer therapiesSTRAUSBERG, Robert L; SIMPSON, Andrew J. G; OLD, Lloyd J et al.Nature (London). 2004, Vol 429, Num 6990, pp 469-474, issn 0028-0836, 6 p.Article

Quantitative and qualitative assessment of circulating NY-ESO-1 specific CD4+ T cells in cancer-free individualsVALMORI, Danila; SOULEIMANIAN, Naira E; HESDORFFER, Charles S et al.Clinical immunology (Orlando, Fla. Print). 2005, Vol 117, Num 2, pp 161-167, issn 1521-6616, 7 p.Article

IFN unresponsiveness in LNCaP cells due to the lack of JAK1 gene expressionDUNN, Gain P; SHEEHAN, Kathleen C. F; OLD, Lloyd J et al.Cancer research (Baltimore). 2005, Vol 65, Num 8, pp 3447-3453, issn 0008-5472, 7 p.Article

Improved Endpoints for Cancer Immunotherapy TrialsHOOS, Axel; EGGERMONT, Alexander M. M; JANETZKI, Sylvia et al.Journal of the National Cancer Institute. 2010, Vol 102, Num 18, pp 1388-1397, issn 0027-8874, 10 p.Article

Tumor-specific Crosslinking of GITR as Costimulation for ImmunotherapyBURCKHART, Tanja; THIEL, Markus; NISHIKAWA, Hiroyoshi et al.Journal of immunotherapy (1997). 2010, Vol 33, Num 9, pp 925-934, issn 1524-9557, 10 p.Article

Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine ConsortiumBRITTEN, Cedrik Michael; JANETZKI, Sylvia; ROMERO, Pedro et al.Cancer immunology and immunotherapy. 2009, Vol 58, Num 10, pp 1701-1713, issn 0340-7004, 13 p.Article

A novel method to localize antibody-targeted cancer deposits intraoperatively using handheld PET beta and gamma probesSTRONG, Vivian E; HUMM, John; RUSSO, Paul et al.Surgical endoscopy. 2008, Vol 22, Num 2, pp 386-391, issn 0930-2794, 6 p.Article

Vaccination with Recombinant NY-ESO-1 Protein Elicits lmmunodominant HLA-DR52b-restricted CD4+ T Cell Responses with a Conserved T Cell Receptor RepertoireBIOLEY, Gilles; DOUSSET, Christelle; YEH, Alice et al.Clinical cancer research (Print). 2009, Vol 15, Num 13, pp 4467-4474, issn 1078-0432, 8 p.Article

Differential expression of CCR7 defines two distinct subsets of human memory CD4+CD25+ TregsTOSELLO, Valeria; ODUNSI, Kunle; SOULEIMANIAN, Naira E et al.Clinical immunology (Orlando, Fla. Print). 2008, Vol 126, Num 3, pp 291-302, issn 1521-6616, 12 p.Article

Induction of regulatory T cell-resistant helper CD4+ T cells by bacterial vectorNISHIKAWA, Hiroyoshi; TSUJI, Takemasa; JÄGER, Elke et al.Blood. 2008, Vol 111, Num 3, pp 1404-1412, issn 0006-4971, 9 p.Article

Monitoring CD4+ T cell responses against viral and tumor antigens using T cells as novel target APCATANACKOVIC, Djordje; MATSUO, Mitsutoshi; RITTER, Erika et al.Journal of immunological methods. 2003, Vol 278, Num 1-2, pp 57-66, issn 0022-1759, 10 p.Article

Cancer/testis antigens: an expanding family of targets for cancer immunotherapySCANLAN, Matthew J; GURE, Ali O; JUNGBLUTH, Achim A et al.Immunological reviews. 2002, Vol 188, pp 22-32, issn 0105-2896, 11 p.Article

IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicitySHANKARAN, Vijay; IKEDA, Hiroaki; BRUCE, Allen T et al.Nature (London). 2001, Vol 410, Num 6832, pp 1107-1111, issn 0028-0836Article

Antibody therapy in renal cell carcinoma : Renal cell carcinomaOOSTERWIJK, Egbert; BOERMAN, Otto C; OYEN, Wim J. C et al.World journal of urology (Print). 2008, Vol 26, Num 2, pp 141-146, issn 0724-4983, 6 p.Article

  • Page / 6